Bayer (BAYRY) Confirms No Restructuring Plans Amid Litigation

AI Summary

Bayer (BAYRY) announced that it has no plans to restructure its operations despite facing ongoing litigation threats. The company aims to maintain its current structure while addressing legal challenges related to product liabilities. This statement implies that Bayer is confident in its existing strategy and operations. The decision could affect investor perception and may influence trading volumes in the related sectors as legal uncertainties often impact stock performance.